Showing results (1-10 of 256) with videos related to
Sort By:
Pageof 26
Cardiac Failure Review|June 13, 2018
Iron Therapy in Heart Failure: Ready for Primetime?Ify R Mordi, Aaron Tee, Chim C LangHeart Failure Clinics|October 10, 2022
Glucose-Lowering and Metabolic Effects of SGLT2 InhibitorsIfy R Mordi, Chim C LangCurrent Opinion in Pharmacology|December 3, 2020
Metformin: still the sweet spot for CV protection in diabetes?Graham Rena, Ify R Mordi, Chim C LangDiseases (Basel, Switzerland)|September 22, 2017
Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart FailureAbbey Steggall, Ify R Mordi, Chim C LangESC Heart Failure|April 3, 2020
Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetesIfy R Mordi, Aaron Tee, Colin N Palmer, et al.Clinical Case Reports|March 26, 2021
Nicorandil-induced colovesical fistula in a patient with diverticular diseaseJames D Noyes, Ify R Mordi, Qaiser Zeb, et al.Expert Opinion on Investigational Drugs|March 27, 2023
Metformin: evidence from preclinical and clinical studies for potential novel applications in cardiovascular diseaseAdel Dihoum, Graham Rena, Ewan R Pearson, et al.Diseases (Basel, Switzerland)|August 27, 2021
Precision Medicine and Adverse Drug Reactions Related to Cardiovascular DrugsJames D Noyes, Ify R Mordi, Alexander S Doney, et al.BMC Cardiovascular Disorders|July 12, 2024
Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophyAdel Dihoum, Alexander Jm Brown, Rory J McCrimmon, et al.Diseases (Basel, Switzerland)|December 22, 2020
Use of Population-Based Health Informatics Research to Improve Care for Patients with Cardiovascular DiseasesIfy R Mordi, Magalie Guignard-Duff, Christopher Hall, et al.Pageof 26